Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5

Clinical Trial ID NCT00722384

PubWeight™ 6.70‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00722384

Top papers

Rank Title Journal Year PubWeight™‹?›
1 RNA-based therapeutics: current progress and future prospects. Chem Biol 2012 3.01
2 Induced pluripotent stem cells in cardiovascular drug discovery. Circ Res 2013 1.22
3 Preclinical and clinical development of siRNA-based therapeutics. Adv Drug Deliv Rev 2015 1.01
4 Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine. Nanomedicine (Lond) 2014 0.94
5 Technologies for controlled, local delivery of siRNA. J Control Release 2015 0.80
Next 100